DOCSLIB.ORG

Lipedema: a Giving Smarter Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lipedema: a Giving Smarter Guide LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FATDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LAIP GOEIDVEMIN AGDI PSOMALGAERSIAT REARRE GADUIPIODSEE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSALGIA LIPOLYMPHEDEMA PAINFUL FAT SYNDROME LIPOEDEM ADIPOALGESIA RARE ADIPOSE DISEASE LIPALGIA PAINFUL FAT DISORDER LIPÖDEM GYNOID LIPOHYPERTROPHY DOLOROSA LIPOEDEEM LIPOMATOSIS DOLOROSA OF THE LEGS LIPOEDEMA ADIPOSA AUTHORS LEAD AUTHOR Erik Lontok, PhD CONTRIBUTING AUTHORS LaTese Briggs, PhD Ebony Mosley Maura Donlan Ekemini A.U. Riley, PhD YooRi Kim, MS Melissa Stevens, MBA LIPEDEMA SCIENTIFIC ADVISORY GROUP We graciously thank the members of the Lipedema Scientific Advisory Group for their participation and contribution to the Lipedema Research Project and Giving Smarter Guide. The informative discussions before, during, and after the Lipedema Scientific Retreat were critical to identifying the unmet needs and philanthropic opportunities to develop the lipedema research space and ultimately benefit lipedema patients. Sara Al-Ghadban, PhD Deborah Clegg, PhD Postdoctoral Research Fellow, Professor, Department of Biomedical Research Department of Medicine Cedars-Sinai Diabetes and Obesity Research TREAT Program Institute University of Arizona Rachelle Crescenzi, PhD Tobias Bertsch, MD, PhD Research Fellow, Institute of Imaging Science Senior Lecturer, Department of Health Vanderbilt University Education, University of Freiburg Senior Consultant, Walter Cromer, PhD Foeldi Clinic, Germany Assistant Research Scientist, Immunology, Vascular Physiology, and Lymphatic Biology Echoe Bouta, PhD Texas A&M Health Science Center Research Fellow, Radiation Oncology Massachusetts General Hospital Kristiana Gordon, MBBS, MRCP, CLT, MD(Res) Consultant in Dermatology and Glen Brice Lymphovascular Medicine, Genetic Counselor, Clinical Genetics St. George’s, University of London St. George’s, University of London Carol Haft, PhD Bruce A. Bunnell, PhD Program Director, Division of Diabetes, Professor, Department of Pharmacology Endocrinology, and Metabolic Diseases Director, Tulane Center for Stem Cell Research National Institute of Diabetes and Digestive and Chairman, Division of Gene Therapy, Tulane Kidney Diseases, National Institutes of Health National Primate Research Center Tulane University School of Medicine ` Natasha Harvey, PhD Tim Padera, PhD Head, Lymphatic Development Laboratory Associate Professor, Radiation Oncology, Centre for Cancer Biology Massachusetts General Hospital and Harvard University of South Australia Medical School Ad Hendrickx, BHS, Physical Therapist Neil Piller, PhD, FACP Doctoral Candidate, Hanze University of Applied Director, Lymphoedema Clinical Research Unit Sciences, Groningen Professor, Department of Surgery Head, Department of Physical Therapy, Expert Flinders Medical Centre Centre for Lymphovascular Medicine Nij Smellinghe Hospital Joseph Rutkowski, PhD Assistant Professor, Medical Physiology Karen Herbst, PhD, MD Texas A&M College of Medicine Associate Professor of Medicine, Division of Endocrinology Philipp Scherer, PhD Director of the TREAT Program Professor, Department of Internal Medicine University of Arizona Director, Touchstone Diabetes Center The University of Texas Southwestern Medical Yann Klimentidis, PhD Center Assistant Professor, Department of Epidemiology and Biostatistics Hamish Scott, PhD University of Arizona Head, Department of Molecular Pathology Centre for Cancer Biology Amira Klip, PhD University of South Australia Senior Scientist, Cell Biology Program, The Hospital for Sick Children, Eva Sevick-Muraca, PhD Professor of Biochemistry, Physiology and Professor, Cullen Chair in Molecular Medicine Paediatrics, The University of Toronto Director, Center for Molecular Imaging University of Texas Health Science Center, Babak Mehrara, MD Houston Physician-scientist, Plastic and Reconstructive Surgery Carrie Shawber, PhD Memorial Sloan Kettering Cancer Center Assistant Professor, Reproductive Sciences in OB/GYN & Surgery Department of Obstetrics & Chia-Ling Nhan-Chang, MD, MS, FACOG Gynecology Assistant Clinical Professor of Obstetrics and Columbia University Medical Center Gynecology, Division of Maternal Fetal Medicine Department of Obstetrics & Gynecology Melody Swartz, PhD Columbia University Medical Center William B. Ogden Professor, Institute for Molecular Engineering Pia Ostergaard, PhD University of Chicago Senior Lecturer in Human Genetics, Institute of Cardiovascular and Cell Sciences St. George’s, University of London Jens Marc Titze, MD Peter Wang Associate Professor, Department of Medicine, Doctoral Candidate, Molecular Physiology and Biophysics Department of Pathology and Immunology Vanderbilt University Washington University, School of Medicine H. Eser Tolunay, PhD Annalisa Zecchin, PhD Deputy Chief, Vascular Biology and Postdoctoral Fellow, Hypertension Branch Laboratory of Angiogenesis and Vascular Division of Cardiovascular Sciences Metabolism National Heart, Lung, and Blood Institute Vesalius Research Center (VRC) National Institutes of Health VIB-KULeuven Henricus Gerardus Jacobus Voesten, MD General and Endovascular Surgery Chief Surgeon, Expert Centre for Lymphovascular Medicine Nij Smellinghe Hospital LIPEDEMA FOUNDATION REPRESENTATIVES Felicitie Daftuar, MBA Founder and Executive Director Board Member and Former President, Fat Disorders Research Society Danielle Wildstein Vice President, Operations Shannon Seeberg Vice President,
Load more

Recommended publications
  • Adipose Tissue As Pain Generator in the Lower Back and Lower Extremity
    Lee et al. HCA Healthcare Journal of Medicine (2020) 1:5 https://doi.org/10.36518/2689-0216.1102 Clinical Review Adipose Tissue as Pain Generator in the Lower Back and Lower Extremity: Application in Author affiliations are listed Musculoskeletal Medicine at the end of this article. Se Won Lee, MD ,1 Craig Van Dien, MD ,2 Sun Jae Won, MD, PhD3 Correspondence to: Se Won Lee, MD Abstract Department of Physical Medicine and Rehabilitation Description MoutainView Medical Adipose tissue (AT) has diverse and important functions in body insulation, mechanical protection, energy metabolism and the endocrine system. Despite its relative abundance in Center the human body, the clinical significance of AT in musculoskeletal (MSK) medicine, partic- 2880 N Tenaya Way, 2nd Fl, ularly its role in painful MSK conditions, is under-recognized. Pain associated with AT can Las Vegas, NV 89128 be divided into intrinsic (AT as a primary pain generator), extrinsic (AT as a secondary pain ([email protected]) generator) or mixed origin. Understanding AT as an MSK pain generator, both by mechanism and its specific role in pain generation by body region, enhances the clinical decision-making process and guides therapeutic strategies in patients with AT-related MSK disorders. This article reviews the existing literature of AT in the context of pain generation in the lower back and lower extremity to increase clinician awareness and stimulate further investigation into AT in MSK medicine. Keywords adipose tissue; fat pad; musculoskeletal pain; connective tissue; lipodystrophy; lipoma; obe- sity; lipedema; pain generator Introduction lower extremity, focusing on its pathogenic role Mounting evidence supports the various func- as a pain generator as well as practical diagno- tions of adipose tissue (AT), most notably its sis and management.
    [Show full text]
  • AHJ Interview Catalog 7-1-13(9)
    Interview Catalog Cross Referenced by Topic Revised 7/1/2020 * Super Segments (SS) TOPIC INTERVIEWEE (A) ABDOMINAL AORTIC ANEURYSMS: AAA – Abdominal Aortic Aneurysm………………………………………….Rama Thumati, MD Abdominal Aortic Aneurysms………………………………………………..Richard Doering, MD Diagnosis & Treatments…………………………………………………………..…...Wang Teng, MD Abdominal Aortic Aneurysms……………………………………………...Theodore Teruya, MD Aortic Aneurysms...............................................................Russell Montgomery, MD ACID REFLUX DISEASE (GERD): Acid Reflux in Children...................................................................Mitchell Katz, MD Acid Reflux Disease……………………………………………………………….….John De Banto, MD GERD Common Symptoms……………………………………………………..Sajen Mathews, MD Treatments Available for Acid Reflux Disease............................Sajen Mathews, MD Range of Treatments for GERDS.................................................Kenneth Chang, MD Prevention & Modern Treatments......................................Parminder Dhaliwal, MD Heartburn & Acid reflux………...............................................Christopher Hurley, MD 7/1/20 Page 1 ACL TEAR (ANTERIOR CRUCIATE LIGAMENT TEAR) ACL Tear/Injuries‐Female Atheletes Prevention....................John A. Schlechter, DO ACNE: Acne……………………………………………………………………………….Sharon Christopher, PA‐C Best Methods of Treating Acne.……………………………………………Gene Rubinstein, MD Flaxel Repair Laser (Part 1)………………………………………………………Michael Persky, MD Flaxel Laser/Recovery & Results (Part 2)………………………………….Michael Persky, MD ACUPUNCTURE:
    [Show full text]
  • Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke
    International Journal of Molecular Sciences Review Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke Yun Hwa Choi 1, Collin Laaker 2, Martin Hsu 2, Peter Cismaru 3, Matyas Sandor 4 and Zsuzsanna Fabry 2,4,* 1 School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] 2 Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] (C.L.); [email protected] (M.H.) 3 Chemistry, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] 4 Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA; [email protected] * Correspondence: [email protected] Abstract: Stroke disrupts the homeostatic balance within the brain and is associated with a significant accumulation of necrotic cellular debris, fluid, and peripheral immune cells in the central nervous system (CNS). Additionally, cells, antigens, and other factors exit the brain into the periphery via damaged blood–brain barrier cells, glymphatic transport mechanisms, and lymphatic vessels, which dramatically influence the systemic immune response and lead to complex neuroimmune communi- cation. As a result, the immunological response after stroke is a highly dynamic event that involves communication between multiple organ systems and cell types, with significant consequences on not only the initial stroke tissue injury but long-term recovery in the CNS. In this review, we discuss the complex immunological and physiological interactions that occur after stroke with a focus on how the peripheral immune system and CNS communicate to regulate post-stroke brain homeostasis. First, Citation: Choi, Y.H.; Laaker, C.; Hsu, we discuss the post-stroke immune cascade across different contexts as well as homeostatic regulation M.; Cismaru, P.; Sandor, M.; Fabry, Z.
    [Show full text]
  • July 14, 2019 the Honorable Jan
    July 14, 2019 The Honorable Jan Schakowsky 2367 Rayburn HOB Washington, DC 20515 Dear Representative Schakowsky: On behalf of University of Pennsylvania Department of Physical Medicine and Rehabilitation, I’m writing to inform you that we would like to offer our formal endorsement of the Lymphedema Treatment Act (S.518/H.R.1948). I am a practicing cancer physiatrist at Penn Medicine and frequently evaluate, diagnose, and manage lymphedema. Many of my patients have lymphedema as a result of cancer treatment, while others have lymphedema as a result of congenital lymphedema, Milroy’s disease, Klippel-Trenaunay Syndrome, lipedema, organ transplantation, chronic venous insufficiency, or trauma. Despite the cause of lymphedema, the international standard of care for treatment includes lymphedema therapy and long term use of compression garments that at a minimum needs to be replaced every 6 months. Lymphedema is a life-long condition that requires ongoing medical management along with continuous compression. The current international standard of care for lymphedema requires use of appropriate compression on a 24-hour basis. Failure to provide adequate compression can lead to significant medical, psychological and functional morbidity. Specifically, patients are left vulnerable to worsening lymphedema, potentially life- threatening cellulitis infections, chronic pain and non-healing wounds. Unfortunately, Medicare currently does not cover these medically necessary compression garments, despite the evidence for the increase in morbidity and mortality associated with untreated lymphedema and the international standard of care to treat with 24-hour compression garments. Furthermore, many patients are unable to financially afford the costs of compression garments that can be several hundred dollars a year.
    [Show full text]
  • Lymphatic Complaints in the Dermatology Clinic: an Osteopathic
    Volume 35 JAOCDJournal Of The American Osteopathic College Of Dermatology Lymphatic Complaints in the Dermatology Clinic: An Osteopathic Approach to Management A five-minute treatment module makes lymphatic OMT a practical option in busy practices. Also in this issue: A Case of Acquired Port-Wine Stain (Fegeler Syndrome) Non-Pharmacologic Interventions in the Prevention of Pediatric Atopic Dermatitis: What the Evidence Says Inflammatory Linear Verrucous Epidermal Nevus Worsening in Pregnancy last modified on June 9, 2016 10:54 AM JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 1 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY 2015-2016 AOCD OFFICERS PRESIDENT Alpesh Desai, DO, FAOCD PRESIDENT-ELECT Karthik Krishnamurthy, DO, FAOCD FIRST VICE-PRESIDENT Daniel Ladd, DO, FAOCD SECOND VICE-PRESIDENT John P. Minni, DO, FAOCD Editor-in-Chief THIRD VICE-PRESIDENT Reagan Anderson, DO, FAOCD Karthik Krishnamurthy, DO SECRETARY-TREASURER Steven Grekin, DO, FAOCD Assistant Editor TRUSTEES Julia Layton, MFA Danica Alexander, DO, FAOCD (2015-2018) Michael Whitworth, DO, FAOCD (2013-2016) Tracy Favreau, DO, FAOCD (2013-2016) David Cleaver, DO, FAOCD (2014-2017) Amy Spizuoco, DO, FAOCD (2014-2017) Peter Saitta, DO, FAOCD (2015-2018) Immediate Past-President Rick Lin, DO, FAOCD EEC Representatives James Bernard, DO, FAOCD Michael Scott, DO, FAOCD Finance Committee Representative Donald Tillman, DO, FAOCD AOBD Representative Michael J. Scott, DO, FAOCD Executive Director Marsha A. Wise, BS AOCD • 2902 N. Baltimore St. • Kirksville, MO 63501 800-449-2623 • FAX: 660-627-2623 • www.aocd.org COPYRIGHT AND PERMISSION: Written permission must be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of more than half a page, tables or figures.
    [Show full text]
  • Surgical Treatments for Lymphedema and Lipedema BACKGROUND
    Name of Blue Advantage Policy: Surgical Treatments for Lymphedema and Lipedema Policy #:719 Latest Review Date: September 2020 Category: Medical/Surgical Policy Grade: B BACKGROUND: Blue Advantage medical policy does not conflict with Local Coverage Determinations (LCDs), Local Medical Review Policies (LMRPs) or National Coverage Determinations (NCDs) or with coverage provisions in Medicare manuals, instructions or operational policy letters. In order to be covered by Blue Advantage the service shall be reasonable and necessary under Title XVIII of the Social Security Act, Section 1862(a)(1)(A). The service is considered reasonable and necessary if it is determined that the service is: 1. Safe and effective; 2. Not experimental or investigational*; 3. Appropriate, including duration and frequency that is considered appropriate for the service, in terms of whether it is: • Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member; • Furnished in a setting appropriate to the patient’s medical needs and condition; • Ordered and furnished by qualified personnel; • One that meets, but does not exceed, the patient’s medical need; and • At least as beneficial as an existing and available medically appropriate alternative. *Routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000 which meet the requirements of the Clinical Trials NCD are considered reasonable and necessary by Medicare. Providers should bill Original Medicare for covered services that are related to clinical trials that meet Medicare requirements (Refer to Medicare National Coverage Determinations Manual, Chapter 1, Section 310 and Medicare Claims Processing Manual Chapter 32, Sections 69.0-69.11).
    [Show full text]
  • Lower Extremity Edema.Pdf
    May 2019 ELDER CARE A Resource for Interprofessional Providers Lower Extremity Edema in Older Adults Oluwaseun O. Acquah, MD, Jennifer M. Vesely, MD, Teresa Quinn, MD, and Donald Pine, MD Family Medicine Residency, University of Minnesota Methodist Hospital Lower extremity edema is the accumulation of fluid in the Bilateral edema, which is more common in older adults, is lower legs, which may or may not include the feet (pedal often multifactorial and may reflect a systemic process. edema). It is typically caused by one of three mechanisms. Treating the underlying systemic cause can often lessen the edema. Table 1 lists common causes of bilateral lower The first is venous edema caused by increased capillary extremity edema. permeability, resulting in a fluid shift from the veins to the interstitial space. The fluid shift can be due to venous In addition to seeking evidence for these conditions, disease or systemic processes that cause the fluid shift. clinicians should be aware of certain clues in the patient’s presentation. In particular, if unilateral edema has an The second is lymphatic edema caused by obstruction or acute-onset (present for less than 72 hours), venous dysfunction of lymphatic outflow from the legs, resulting in thrombosis and infection should be considered as possible accumulation of protein-rich interstitial fluid. causes and steps should be taken to exclude those The third is from lipoedema, which is an accumulation of diagnoses. On the other hand, when edema is long- fluid in fat cells. These three mechanisms can operate standing and accompanied by a dull, aching pain, chronic independently or in combination.
    [Show full text]
  • Sakakawea Dispatch
    Winter 2018-2019 Sakakawea Medical Center Sakakawea Dispatch Inside this issue: This institution is an equal opportunity provider. CCCHC Providers 2 Construction 3 Update for CCCHC Darrold Bertsch, SMC CEO Receives Grassroots Champion Award Emergency 4 Department Each year, the American Hospital Association (AHA), in conjunction with the state hospital associations, recognizes the achievements of grassroots Triage 4 leaders with the prestigious Grassroots Champion Award. One hospital Charity Care 4 leader from each state is honored for his or her work over the previous year in effectively delivering the hospital message to elected officials; Lymphedema helping to broaden the base of community support for hospitals; and 5 Program advocating tirelessly on behalf of patients, hospitals and communities. Patient Satisfaction 5 The American Hospital Association in conjunction with the North Dakota Surveys State Hospital Association named Sakakawea Medical Center, CEO, Stop the Bleed 6 Darrold Bertsch as the 2018 Grassroots Champion. Bertsch earned this special recognition through his dedication to the hospital mission, on both Welcome the local and the national level. 7 Dr. Fogarty Mr. Bertsch was recognized during the during the AHA annual meeting and Tobacco Cessation 7 was presented with the award during the North Dakota Hospital Association annual conference that was held in Fargo, North Dakota. Visiting Specialists 8 Darrold Bertsch, CEO of Sakakawea Medical Center SMC and Jen Porter, American Hospital Association’s Regional Executive for Region 6 How to contact us: Sakakawea Medical Center 510 8th Ave NE Hazen, ND 58545 Phone: 701.748.2225 Fax: 701.748.5757 Visit www.aha.org for more information.
    [Show full text]
  • Lipedema Intake Form
    Lipedema Intake Form (Please complete in addition to a complete health history) Personal Information Name Do you sit for long periods at a work, home or DOB while driving? Yes No Have you been formally diagnosed with lipedema? If yes, please tell me more: Yes No Does someone else in your family have Lipedema? Do you experience stress? Yes No Yes No If yes, please tell me more: Have you been evaluated by an expert? Endocrinologist Yes No Does your stress result in any of these symptoms? Vascular Specialist Yes No (circle all that apply) Nutritionist Yes No muscle tension / anxiety / insomnia / irritability / other Physical Therapy for functional improvement - Is there a particular area of the body where you are (balance and movement) Yes No experiencing tension, stiffness, pain or other discomfort? Psychotherapist Yes No Yes No Other Yes No If yes, please tell me more: Tell me more: Are you experiencing discomfort in your body? Yes No What treatments have you tried in the past? How well did they work? If yes, please tell me more: Tell me more: Do you suffer from chronic pain? Yes No Are you currently under medical supervision for If yes, please tell me more: lipedema, lymphedema or any other condition? Yes No Do you have areas of swelling and/or inflammation? Yes No If yes, please tell me more: If yes, please tell me more: Do you exercise regularly? Yes No Have you had a recent injury or surgery? Yes No If yes, please tell me more: If yes, please tell me more: Do you perform any repetitive movement in your work or at home? Yes No Do you
    [Show full text]
  • 160 Lymphedema in Dengue Fever – an Unreported Case
    Downloaded from www.medrech.com “Lymphedema in dengue fever – An unreported case” Medrech ISSN No. 2394-3971 Case Report LYMPHEDEMA IN DENGUE FEVER – AN UNREPORTED CASE Ching Soong Khoo 1* , Wan Yi Leong 1, Rosaida Md Said 1, Suguna Raman 2, Pushpagandy Ramanathan 2, Petrick Periyasamy 3 1. Department of Internal Medicine/ Ampang Hospital/ Jalan Mewah Utara, Taman Pandan Mewah, 68000 Ampang, Selangor, Malaysia 2. Department of Radiology/ Ampang Hospital/ Jalan Mewah Utara, Taman Pandan Mewah, 68000 Ampang, Selangor, Malaysia 3. University Kebangsaan Malaysia Medical Centre/ Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia Submitted on: October 2015 Accepted on: October 2015 For Correspondence Email ID: Abstract Dengue fever is a neglected tropical disease, which is rearing its ugly head in increasing numbers of both morbidities and mortalities in Malaysia. As of August 18, 2015, a total of 76819 dengue cases and 212 dengue deaths have been reported for 2015 according to Malaysian health officials [1]. Atypical presentations of dengue fever are also on the rise, which are underreported or unrecognized due to lack of awareness [2,3,4]. Lymphedema complicating dengue fever has not been reported in any literature. We detail this case to highlight the varied manifestations of dengue fever. Keywords: Dengue fever, lymphedema Introduction Case Report According to the World Health Organization A 38-year-old Nepalese gentleman (WHO), dengue fever is most commonly an presented to the Emergency Department acute febrile illness defined by the presence with fever for three days, arthralgia, of fever and two or more of the following, myalgia, persistent vomiting, epigastric pain retro-orbital or ocular pain, headache, rash, and productive coughs.
    [Show full text]
  • MR Imaging of the Lymphatic System in Patients with Lipedema and Lipo-Lymphedema
    Microvascular Research 77 (2009) 335–339 Contents lists available at ScienceDirect Microvascular Research journal homepage: www.elsevier.com/locate/ymvre Regular Article MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema Christian Lohrmann a,⁎, Etelka Foeldi b, Mathias Langer a a Department of Radiology, University Hospital of Freiburg, Hugstetter Strasse 55, D-79106, Freiburg i. Br., Germany b Foeldi Clinic for Lymphology, Hinterzarten, Röβlehofweg 2-6, D-79856, Hinterzarten, Germany article info abstract Article history: Objective: To assess for the first time the morphology of the lymphatic system in patients with lipedema and Received 30 October 2008 lipo-lymphedema of the lower extremities by MR lymphangiography. Revised 15 January 2009 Materials and methods: 26 lower extremities in 13 consecutive patients (5 lipedema, 8 lipo-lymphedema) Accepted 15 January 2009 were examined by MR lymphangiography. 18 mL of gadoteridol and 1 mL of mepivacainhydrochloride 1% Available online 27 January 2009 were subdivided into 10 portions and injected intracutaneously in the forefoot. MR imaging was performed with a 1.5-T system equipped with high-performance gradients. For MR lymphangiography, a 3D-spoiled Keywords: Lipedema gradient-echo sequence was used. For evaluation of the lymphedema a heavily T2-weighted 3D-TSE Lipo-lymphedema sequence was performed. MRI Results: In all 16 lower extremities (100%) with lipo-lymphedema, high signal intensity areas in the epifascial Lymphangiography region could be detected on the 3D-TSE sequence. In the 16 examined lower extremities with lipo- Microcirculation lymphedema, 8 lower legs and 3 upper legs demonstrated enlarged lymphatic vessels up to a diameter of 3 mm.
    [Show full text]
  • Best Practice Guidelines
    WUK BPG Best Practice Guidelines Te management of lipoedema 2017 Diagnosis and assessment Lipoedema management Life style support and self care Compression therapy Non-surgical and surgical interventions BEST PRACTICE GUIDELINES: EXPERT WORKING GROUP: THE MANAGEMENT OF Tanya Coppel, Specialist Lymphoedema Physiotherapist, LIPOEDEMA Belfast Health & Social Care Trust, Belfast PUBLISHED BY: Julie Cunneen, Macmillan Clinical Lead for Wounds UK Lymphoedema Service/Nurse Consultant, Moseley Hall Hospital, Birmingham A division of Omniamed, 1.01 Cargo Works Sharie Fetzer, Chair, Lipoedema UK, London 1–2 Hatfields, London SE1 9PG, UK Tel: +44 (0)203735 8244 Kristiana Gordon, Consultant in Dermatology and Web: www.wounds-uk.com Lymphovascular Medicine, St George’s Hospital, London Denise Hardy, Lymphoedema/Lipoedema Nurse Consultant, Kendal Lymphology Centre, Kendal, Cumbria; Nurse Adviser, Lipoedema UK/ Lymphoedema Support Network (LSN), Cumbria; Co- Chair of the Expert Working Group © Wounds UK, March 2017 Tis document has been developed Kris Jones, Patient; Joint Managing Director & Nurse by Wounds UK and is supported byActiva Healthcare, BSN Consultant, LymphCare UK; Nurse Consultant, Medical, Haddenham Healthcare, Lipoedema UK Lipoedema UK, medi UK, Sigvaris and Talk Lipoedema. Angela McCarroll, Trustee, Talk Lipoedema; Patient, Northern Ireland Caitriona O’Neill, Lymphoedema Care Lead Nurse, Accelerate CIC, London Sara Smith, Senior Lecturer in Dietetics and Nutrition, Queen Margaret University, Edinburgh Cheryl White, Lymphoedema Specialist
    [Show full text]